Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Satoshi Morita
Journal Article
Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT)
The Oncologist, Volume 26, Issue 6, June 2021, Pages e954–e962, https://doi.org/10.1002/onco.13735
Published: 23 March 2021
Journal Article
Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study
The Oncologist, Volume 25, Issue 4, April 2020, Pages e668–e674, https://doi.org/10.1634/theoncologist.2019-0593
Published: 26 November 2019
Journal Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study
The Oncologist, Volume 23, Issue 10, October 2018, Pages 1210–1217, https://doi.org/10.1634/theoncologist.2017-0586
Published: 23 March 2018
Journal Article
A Phase I/II Study of XELIRI Plus Bevacizumab as Second‐Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)
The Oncologist, Volume 19, Issue 11, November 2014, Pages 1131–1132, https://doi.org/10.1634/theoncologist.2014-0159
Published: 03 October 2014
Journal Article
Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy
The Oncologist, Volume 17, Issue 9, September 2012, Pages 1163–1170, https://doi.org/10.1634/theoncologist.2012-0079
Published: 23 May 2012
Journal Article
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial
The Oncologist, Volume 17, Issue 6, June 2012, Pages 863–870, https://doi.org/10.1634/theoncologist.2011-0426
Published: 11 May 2012
